Clinical trial

Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC

NCT01088906

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE2

Study timeline

Study start (unknown)2010-01-01Date precision: month

Registry last updated2024-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non Small Cell Lungunresolved

Interventions

Pemetrexed/CisplatinDRUG

Sponsors & collaborators

Spanish Lung Cancer Grouplead sponsor

Mapped research locations

MadridSpain2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01088906 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.